Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib helped a young woman's severe hair loss and arthritis but not her plaque psoriasis.

Ruxolitinib cream effectively targets and treats inflammatory skin diseases.

Sorafenib can cause a unique skin reaction.

Gemcitabine and Disitamab Vedotin effectively and safely reduced bladder cancer in a patient.

Erlotinib may cause scarring hair loss.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Sorafenib can cause delayed skin problems, so patients need careful monitoring.

Upadacitinib improved symptoms and hair regrowth in a teen with multiple autoimmune conditions.

Ritlecitinib may cause serious side effects like blood clots in alopecia areata patients.

Continuous treatment with ritlecitinib and brepocitinib is needed to maintain hair regrowth in alopecia areata.

Upadacitinib may effectively treat alopecia areata without side effects.

Upadacitinib significantly improved both rheumatoid arthritis and alopecia areata in a patient.

Baricitinib is an effective treatment for severe alopecia areata.

Tofacitinib regrew hair in a man with total hair loss but raised cytokine levels, needing more research on possible side effects.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

Erlotinib can cause hair loss and scalp issues, which improve after stopping the drug.

Tofacitinib, a hair regrowth treatment, may worsen acne.

Erlotinib can cause hair loss as a side effect.

Baricitinib may cause low blood sugar in some patients, so careful monitoring is needed.

Folliculin helps regulate energy and nutrient sensing, impacting Birt–Hogg–Dubé syndrome.

Tofacitinib is more effective than traditional treatments for severe alopecia areata in children.

Peficitinib can turn human fibroblasts into cells that help grow hair.

Ritlecitinib effectively improves hair growth in alopecia areata patients, regardless of hair loss pattern.

Erlotinib can cause hair loss and texture changes.

JAK inhibitors like tofacitinib can effectively treat severe alopecia areata.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Baricitinib helped regrow hair in patients with severe alopecia areata after other treatments failed.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

China approved Sinovac's flu vaccine, Japan approved RiUP for female hair loss, and Nippon Kayaku's three cancer drugs.